SuRo Capital Corp. (“SuRo Capital”, the
“Company”, “we”, “us”, and “our”) (Nasdaq:
SSSS) today announced its financial results for
the fourth quarter and fiscal year ended December 31, 2024. Net
assets totaled approximately $157.6 million, or $6.68 per share, at
December 31, 2024, as compared to $6.73 per share at September 30,
2024 and $7.99 per share at December 31, 2023.
“Since inception, SuRo Capital has served as the
public's gateway to venture capital, offering unique access to some
of the world’s most innovative and sought-after private companies
before they become publicly traded. Our diverse portfolio
encompasses high-growth sectors including AI infrastructure,
emerging consumer brands, and cutting-edge software solutions for
both consumer and enterprise markets, among others,” said Mark
Klein, Chairman and Chief Executive Officer of SuRo Capital.
“This is an exceptionally promising time for our
portfolio,” Mr. Klein continued. “CoreWeave, the single largest
initial investment in our fund’s history, filed for an IPO earlier
this month. This follows our portfolio company ServiceTitan’s
successful IPO late last year. We are also extremely excited about
the prospect of IPOs in some of our larger investments, like Canva,
Whoop, Liquid Death, Vast Data, and OpenAI. We believe this moment
is reminiscent of 2020 and 2021, when we monetized a substantial
portion of our portfolio assets. I am confident that our current
positioning is as strong as ever.”
Mr. Klein then highlighted SuRo Capital’s recent
investment activity, noting, “In 2024, we continued to execute on a
disciplined approach to deploying capital, and we have begun to see
the positive results of those efforts as 2024 marked one of our
most active investment periods in the last decade. During the year,
we invested $54.5 million in artificial intelligence infrastructure
and applications through our investments in CoreWeave (in part
through CW Opportunity 2 LP, an SPV invested in CoreWeave, Inc.),
OpenAI (through ARK Type One Deep Ventures Fund LLC, an SPV), and
VAST (through IH10, LLC, an SPV). Additionally, we are pleased to
report the full exit of our position in Oklo achieving a
significant return of over 20 times our initially invested capital
in AltC Sponsor LLC and the full exit of our PublicSquare common
shares following the successful merger with Colombier Acquisition
Corp. in 2023. These realizations are a testament to the success of
our SPAC sponsor strategy established several years ago.”
Investment Portfolio as of December 31,
2024
At December 31, 2024, SuRo Capital held
positions in 37 portfolio companies – 33 privately held and 4
publicly held, some of which may be subject to certain restrictions
and/or lock-up provisions – with an aggregate fair value of
approximately $209.4 million. The Company’s top five portfolio
company investments accounted for approximately 44% of the total
portfolio at fair value as of December 31, 2024.
Top Five Investments as of December 31,
2024
Portfolio Company ($ in millions) |
Cost Basis |
Fair Value |
% of Total Portfolio |
CW Opportunity 2 LP & CoreWeave, Inc.(1) |
$ |
25.2 |
$ |
28.2 |
13.5 |
% |
ARK Type One Deep Ventures
Fund LLC(2) |
|
17.7 |
|
17.6 |
8.4 |
|
Learneo, Inc. |
|
15.0 |
|
16.9 |
8.1 |
|
Blink Health, Inc. |
|
15.0 |
|
15.1 |
7.2 |
|
Whoop, Inc. |
|
10.0 |
|
14.9 |
7.1 |
|
Total(3) |
$ |
82.9 |
$ |
92.8 |
44.3 |
% |
___________________(1) Includes SuRo Capital’s $15.0 million
investment in CW Opportunity 2 LP, $5.0 million secondary
investment in CoreWeave, Inc. common shares, and $5.0 million
secondary investment in CoreWeave, Inc. Series A Preferred Shares.
CW Opportunity 2 LP is an SPV that is solely invested in the Series
C Preferred Shares of CoreWeave, Inc. SuRo Capital is invested in
the Series C Preferred Shares of CoreWeave, Inc. through its
investment in the Class A Interest of CW Opportunity 2 LP.(2) ARK
Type One Deep Ventures Fund LLC is an investment fund for which the
Class A Interest is solely invested in the Convertible Interest
Rights of OpenAI Global, LLC. SuRo Capital is invested in the
Convertible Interest Rights of OpenAI Global, LLC through its
investment in the Class A Interest of ARK Type One Deep Ventures
Fund LLC.(3) Total may not sum due to rounding.
Fourth Quarter 2024 Investment Portfolio
Activity
During the three months ended December 31, 2024, SuRo Capital
made the following investments:
Portfolio Company |
Investment |
Transaction Date |
Amount(1) |
CoreWeave, Inc.(2) |
Series A Preferred Shares |
10/8/2024 |
$5.0 million |
IH10, LLC(3) |
Membership Interest |
10/9/2024 |
$12.0 million |
___________________(1) Amount invested does not include any
capitalized costs or prepaid management fees or fund expenses, if
applicable.(2) In aggregate, SuRo Capital invested $15 million in
CW Opportunity 2 LP, $5 million in CoreWeave, Inc. common shares,
and $5 million in CoreWeave, Inc. Series A Preferred Shares. CW
Opportunity 2 LP is an SPV that is solely invested in the Series C
Preferred Shares of CoreWeave, Inc. SuRo Capital is invested in the
Series C Preferred Shares of CoreWeave, Inc. through its investment
in the Class A Interest of CW Opportunity 2 LP.(3) IH10, LLC’s sole
portfolio asset is interest in the Series B Preferred Shares of
VAST Data, Ltd. through an SPV. SuRo Capital is invested in the
Series B Preferred Shares of VAST Data, Ltd. through its investment
in the Membership Interest of IH10, LLC.
During the three months ended December 31, 2024,
SuRo Capital exited or received proceeds from the following
investments:
Portfolio Company |
TransactionDate |
Quantity |
Average NetShare Price(1) |
NetProceeds |
RealizedGain |
Oklo, Inc. |
11/15/2024 |
239,300 |
$21.14 |
$5.1 million |
$4.8 million |
PSQ Holdings, Inc. (d/b/a
PublicSquare) – Public Common Shares(2) |
Various |
1,616,187 |
$3.28 |
$5.3 million |
$4.0 million |
PSQ Holdings, Inc. (d/b/a
PublicSquare) – Public Warrants(3) |
Various |
500,000 |
$1.08 |
$0.5 million |
$0.3 million |
Forge Global, Inc.(4) |
Various |
125,000 |
$1.03 |
$0.1 million |
<$0.1 million |
True Global Ventures 4 Plus
Pte Ltd |
12/23/2024 |
N/A |
N/A |
$0.1 million |
$- |
__________________(1)
The average net share price is the net share price realized after
deducting all commissions and fees on the sale(s), if
applicable.(2) As of December 3, 2024, SuRo Capital had sold its
remaining PSQ Holdings, Inc. (d/b/a PublicSquare) public common
shares.(3) As of December 31, 2024, SuRo Capital held 1,796,037
remaining PSQ Holdings, Inc. (d/b/a PublicSquare) public
warrants.(4) As of December 31, 2024, SuRo Capital held 1,020,875
remaining Forge Global, Inc. public common shares.
Subsequent to year-end through March 11, 2025,
SuRo Capital made the following follow-on investments:
Portfolio Company |
Investment |
Transaction Date |
Amount(1) |
Orchard Technologies,
Inc. |
Series 1 Senior Preferred |
1/31/2025 |
$0.2 million |
Orchard Technologies,
Inc. |
Simple Agreement for Future Equity |
1/31/2025 |
$0.1 million |
Whoop, Inc. |
Simple Agreement for Future Equity |
2/6/2025 |
$1.0 million |
__________________(1) Amount invested
does not include any capitalized costs, if applicable.
Fourth Quarter 2024 Financial
Results
|
Quarter EndedDecember 31,
2024 |
Quarter EndedDecember 31,
2023 |
$ in millions |
per share(1) |
$ in millions |
per share(1) |
|
|
|
|
|
Net investment loss |
$(3.9 |
) |
$(0.16 |
) |
$(2.7 |
) |
$(0.11 |
) |
|
|
|
|
|
Net realized gain on
investments |
9.1 |
|
0.39 |
|
2.6 |
|
0.10 |
|
|
|
|
|
|
Realized loss on partial
repurchase of 6.00% Notes due 2026 |
(<0.1 |
) |
(<0.01 |
) |
- |
|
- |
|
|
|
|
|
|
Net change in unrealized
appreciation/(depreciation) of investments |
(5.2 |
) |
(0.22 |
) |
(9.0 |
) |
(0.36 |
) |
|
|
|
|
|
Net increase/(decrease) in net
assets resulting from operations – basic(2) |
<0.1 |
|
<0.01 |
|
(9.1 |
) |
(0.37 |
) |
|
|
|
|
|
Stock-based compensation |
0.1 |
|
(0.06 |
) |
0.5 |
|
(0.06 |
) |
|
|
|
|
|
Increase/(decrease) in net asset value(2) |
$0.1 |
|
$(0.05 |
) |
$(8.7 |
) |
$(0.43 |
) |
__________________(1)
Based on basic weighted-average number of shares outstanding for
the relevant period.(2) Total may not sum due to rounding.
Fiscal Year 2024 Financial
Results
|
Fiscal Year EndedDecember 31,
2024 |
Fiscal Year EndedDecember 31,
2023 |
$ in millions |
per share(1) |
$ in millions |
per share(1) |
|
|
|
|
|
Net investment loss |
$(14.0 |
) |
$(0.58 |
) |
$(13.4 |
) |
$(0.51 |
) |
|
|
|
|
|
Net realized loss on
investments |
(5.0 |
) |
(0.21 |
) |
(11.9 |
) |
(0.46 |
) |
|
|
|
|
|
Realized loss on partial
repurchase of 6.00% Notes due 2026 |
(0.2 |
) |
(0.01 |
) |
- |
|
- |
|
|
|
|
|
|
Net change in unrealized
appreciation/(depreciation) of investments |
(19.0 |
) |
(0.79 |
) |
30.5 |
|
1.16 |
|
|
|
|
|
|
Net increase/(decrease) in net
assets resulting from operations – basic(3) |
(38.1 |
) |
(1.59 |
) |
5.1 |
|
0.19 |
|
|
|
|
|
|
Stock-based compensation |
1.7 |
|
0.11 |
|
2.4 |
|
0.09 |
|
|
|
|
|
|
Repurchase of common
stock(2) |
(9.4 |
) |
0.17 |
|
(14.2 |
) |
0.32 |
|
|
|
|
|
|
Increase/(decrease) in net asset value(3) |
$(45.8 |
) |
($1.31 |
) |
$(6.7 |
) |
$0.60 |
|
__________________(1)
Based on weighted-average number of shares outstanding for the
relevant period.(2) Includes tender offers. The use of cash in
connection with the repurchases decreased net asset value as of
each year-end; however, the reduction in shares outstanding as of
each year-end resulted in an increase to net asset value per
share.(3) Total may not sum due to rounding.
Weighted-average common basic shares outstanding
were approximately 23.9 million and 26.2 million for the years
ended December 31, 2024 and 2023, respectively. As of December 31,
2024, there were 23,601,566 shares of the Company’s common stock
outstanding.
SuRo Capital’s liquid assets were approximately
$23.6 million as of December 31, 2024, consisting of cash and
securities of publicly traded portfolio companies not subject to
certain restrictions at year-end.
Convertible Note Purchase
Agreement
On August 6, 2024, SuRo Capital entered into a
Note Purchase Agreement (the “Note Purchase Agreement”), by and
between the Company and the purchaser identified therein (the
“Purchaser”), pursuant to which we may issue up to a maximum of
$75.0 million in aggregate principal amount of 6.50% Convertible
Notes due 2029 (the “Convertible Notes”). Pursuant to the Note
Purchase Agreement, on August 14, 2024 we issued and sold, and the
Purchaser purchased, $25.0 million in aggregate principal amount of
the Convertible Notes (the “Initial Notes”). Under the Note
Purchase Agreement, upon mutual agreement between the Company and
the Purchaser, we may issue additional Convertible Notes for sale
in subsequent offerings to the Purchaser (the “Additional Notes”),
or issue additional notes with modified pricing terms (the “New
Notes”), in the aggregate for both the Additional Notes and the New
Notes, up to a maximum of $50.0 million in one or more private
offerings.
Interest on the Convertible Notes will be paid
quarterly in arrears on March 30, June 30, September 30, and
December 30, at a rate of 6.50% per year. The Convertible Notes
will mature on August 14, 2029, and may be redeemed in whole or in
part at any time or from time to time at our option on or after
August 6, 2027 upon the fulfillment of certain conditions. The
Convertible Notes will be convertible into shares of our common
stock at the Purchaser's sole discretion at an initial conversion
rate of 129.0323 shares of our common stock per $1,000 principal
amount of the Convertible Notes, subject to adjustments and
limitations as provided in the Note Purchase Agreement. The net
proceeds from the offering of the Convertible Notes will be used to
repay outstanding indebtedness, make investments in accordance with
our investment objective and investment strategy, and for other
general corporate purposes. The Note Purchase Agreement includes
customary representations, warranties, and covenants by the
Company.
On October 9, 2024, pursuant to the Note
Purchase Agreement, we issued and sold, and the Purchaser
purchased, $5.0 million in aggregate principal amount of the
Additional Notes. Subsequent to year-end, pursuant to the Note
Purchase Agreement, on January 16, 2025 we issued and sold, and the
Purchaser purchased, $5.0 million in aggregate principal amount of
the Additional Notes. The Additional Notes are treated as a single
series with the Initial Notes and have the same terms as the
Initial Notes. The Additional Notes are fungible and rank equally
with the Initial Notes. Upon issuance of the Additional Notes on
January 16, 2025, the outstanding aggregate principal amount of our
Convertible Notes became $35.0 million.
Note Repurchase Program
On August 6, 2024, SuRo Capital’s Board of
Directors approved a discretionary note repurchase program (the
“Note Repurchase Program”) which allows the Company to repurchase
up to $35.0 million of our 6.00% Notes due 2026, exclusive of any
applicable fees, through open market purchases, including block
purchases, in such manner as will comply with the provisions of the
Investment Company Act of 1940, as amended (the "1940 Act") and the
Securities Exchange Act of 1934, as amended (the "Exchange
Act").
During the quarter ended December 31, 2024, we
repurchased an additional 203,168 of the 6.00% Notes due 2026 under
the Note Repurchase Program. As of December 31, 2024, we had
repurchased 1,213,304 of the 6.00% Notes due 2026 under the Note
Repurchase Program. Subsequent to year-end, through March 11, 2025,
we repurchased an additional 199,990 of the 6.00% Notes due 2026
under the Note Repurchase Program. As of March 11, 2025, $35.3
million in aggregate principal dollar amount of the 6.00% Notes due
2026 have been repurchased, resulting in the total use of the
authorized available funds.
Share Repurchase Program
On October 29, 2024, the Company’s Board of
Directors authorized an extension of, and a $4.3 million increase
in the amount of shares that may be repurchased under, the
Company's discretionary Share Repurchase Program until the earlier
of (i) October 31, 2025 or (ii) the repurchase of $64.3 million in
aggregate amount of the Company's common stock. As of March 11,
2025, the dollar value of shares that may yet be purchased by the
Company under the Share Repurchase Program is approximately $25.0
million.
Since inception of the Share Repurchase Program
in August 2017, SuRo Capital has repurchased over 6.0 million
shares of its common stock for an aggregate purchase price of
approximately $39.3 million.
Under the Share Repurchase Program, the Company
may repurchase its outstanding common stock in the open market,
provided it complies with the prohibitions under its insider
trading policies and procedures and the applicable provisions of
the 1940 Act and the Exchange Act.
Conference Call and Webcast
Management will hold a conference call and
webcast for investors at 2:00 p.m. PT (5:00 p.m. ET) on March 11,
2025. The conference call access number for U.S. participants is
866-580-3963, and the conference call access number for
participants outside the U.S. is +1 786-697-3501. The conference ID
number for both access numbers is 6936935 or SuRo Capital.
Additionally, interested parties can listen to a live webcast of
the call from the "Investor Relations" section of SuRo Capital’s
website at www.surocap.com. An archived replay of the webcast will
also be available for 12 months following the live
presentation.
A replay of the conference call may be accessed
until 5:00 p.m. PT (8:00 p.m. ET) on March 18, 2025 by dialing
866-583-1035 (U.S.) or +44 (0) 20 3451 9993 (International) and
using conference ID number 6936935.
Forward-Looking Statements
Statements included herein, including statements
regarding SuRo Capital's beliefs, expectations, intentions, or
strategies for the future, may constitute "forward-looking
statements". SuRo Capital cautions you that forward-looking
statements are not guarantees of future performance and that actual
results or developments may differ materially from those projected
or implied in these statements. All forward-looking statements
involve a number of risks and uncertainties, including the impact
of any market volatility that may be detrimental to our business,
our portfolio companies, our industry, and the global economy, that
could cause actual results to differ materially from the plans,
intentions, and expectations reflected in or suggested by the
forward-looking statements. Risk factors, cautionary statements,
and other conditions which could cause SuRo Capital's actual
results to differ from management's current expectations are
contained in SuRo Capital's filings with the Securities and
Exchange Commission. SuRo Capital undertakes no obligation to
update any forward-looking statement to reflect events or
circumstances that may arise after the date of this press
release.
About SuRo Capital Corp.
SuRo Capital Corp. (Nasdaq: SSSS) is a publicly
traded investment fund that seeks to invest in high-growth,
venture-backed private companies. The fund seeks to create a
portfolio of high-growth emerging private companies via a
repeatable and disciplined investment approach, as well as to
provide investors with access to such companies through its
publicly traded common stock. SuRo Capital is headquartered in New
York, NY and has offices in San Francisco, CA. Connect with the
company on X, LinkedIn, and at www.surocap.com.
ContactSuRo Capital Corp.(212)
931-6331IR@surocap.com
SURO CAPITAL CORP. AND
SUBSIDIARIESCONSOLIDATED STATEMENTS OF ASSETS AND
LIABILITIES |
|
|
December 31, 2024 |
|
December 31, 2023 |
ASSETS |
|
|
|
Investments at fair
value: |
|
|
|
Non-controlled/non-affiliate investments (cost of $234,601,314 and
$160,994,161, respectively) |
$ |
198,511,915 |
|
|
$ |
147,167,535 |
|
Non-controlled/affiliate
investments (cost of $20,605,400 and $32,775,940,
respectively) |
|
9,268,827 |
|
|
|
24,931,333 |
|
Controlled investments (cost
of $1,602,940 and $18,771,097, respectively) |
|
1,600,000 |
|
|
|
11,982,381 |
|
Total Portfolio Investments |
|
209,380,742 |
|
|
|
184,081,249 |
|
Investments in U.S. Treasury
bills (cost of $0 and $63,792,704, respectively) |
|
— |
|
|
|
63,810,855 |
|
Total Investments (cost of
$256,809,654 and $276,333,902, respectively) |
|
209,380,742 |
|
|
|
247,892,104 |
|
Cash |
|
20,035,640 |
|
|
|
28,178,352 |
|
Escrow proceeds
receivable |
|
45,298 |
|
|
|
309,293 |
|
Interest and dividends
receivable |
|
756,022 |
|
|
|
132,607 |
|
Deferred financing costs |
|
526,261 |
|
|
|
594,726 |
|
Prepaid expenses and other
assets(1) |
|
855,630 |
|
|
|
494,602 |
|
Total Assets |
|
231,599,593 |
|
|
|
277,601,684 |
|
LIABILITIES |
|
|
|
6.00% Notes due December 30,
2026(2) |
|
44,198,838 |
|
|
|
73,745,207 |
|
6.50% Convertible Notes due
August 14, 2029(3) |
|
29,051,408 |
|
|
|
— |
|
Accounts payable and accrued
expenses(1) |
|
768,394 |
|
|
|
346,308 |
|
Dividends payable |
|
8,867 |
|
|
|
152,523 |
|
Total Liabilities |
|
74,027,507 |
|
|
|
74,244,038 |
|
|
|
|
|
Net
Assets |
$ |
157,572,086 |
|
|
$ |
203,357,646 |
|
NET
ASSETS |
|
|
|
Common stock, par value $0.01
per share (100,000,000 authorized; 23,601,566 and 25,445,805 issued
and outstanding, respectively) |
$ |
236,016 |
|
|
$ |
254,458 |
|
Paid-in capital in excess of
par |
|
226,579,432 |
|
|
|
248,454,107 |
|
Accumulated net investment
loss |
|
(4,302,192 |
) |
|
|
(4,304,111 |
) |
Accumulated net realized loss
on investments, net of distributions |
|
(17,409,097 |
) |
|
|
(12,348,772 |
) |
Accumulated net unrealized
appreciation/(depreciation) of investments |
|
(47,532,073 |
) |
|
|
(28,698,036 |
) |
Net Assets |
$ |
157,572,086 |
|
|
$ |
203,357,646 |
|
Net Asset Value Per Share |
$ |
6.68 |
|
|
$ |
7.99 |
|
__________________(1) This balance includes a
right of use asset and corresponding operating lease liability,
respectively.(2) As of December 31, 2024, the 6.00% Notes due
December 30, 2026 (the "6.00% Notes due 2026") (effective interest
rate of 6.48%) had a face value $44,667,400. As of December 31,
2023, the 6.00% Notes due 2026 (effective interest rate of 6.53%)
had a face value $75,000,000.(3) As of December 31, 2024, the 6.50%
Convertible Notes due August 14, 2029 (the "6.50% Convertible Notes
due 2029") (effective interest rate of 7.06%) had a face value
$30,000,000.
SURO CAPITAL CORP. AND
SUBSIDIARIESCONSOLIDATED STATEMENTS OF
OPERATIONS |
|
|
|
Year Ended December 31, |
|
|
|
2024 |
|
|
|
2023 |
|
|
|
2022 |
|
INVESTMENT
INCOME |
|
|
|
|
|
|
Non-controlled/non-affiliate
investments: |
|
|
|
|
|
|
Interest income(1) |
|
$ |
1,296,415 |
|
|
$ |
795,847 |
|
|
$ |
403,029 |
|
Dividend income |
|
|
1,232,239 |
|
|
|
211,310 |
|
|
|
541,239 |
|
Controlled investments: |
|
|
|
|
|
|
Interest income |
|
|
955,628 |
|
|
|
1,331,258 |
|
|
|
1,685,000 |
|
Dividend income |
|
|
— |
|
|
|
500,000 |
|
|
|
— |
|
Interest income from U.S.
Treasury bills |
|
|
1,189,145 |
|
|
|
3,758,365 |
|
|
|
826,925 |
|
Total Investment Income |
|
|
4,673,427 |
|
|
|
6,596,780 |
|
|
|
3,456,193 |
|
OPERATING
EXPENSES |
|
|
|
|
|
|
Compensation expense |
|
|
9,159,673 |
|
|
|
9,482,867 |
|
|
|
7,566,452 |
|
Interest expense |
|
|
4,843,570 |
|
|
|
4,858,049 |
|
|
|
4,845,549 |
|
Professional fees |
|
|
2,277,765 |
|
|
|
2,602,894 |
|
|
|
3,395,260 |
|
Directors’ fees |
|
|
682,260 |
|
|
|
645,548 |
|
|
|
675,716 |
|
Income tax expense |
|
|
88,692 |
|
|
|
624,049 |
|
|
|
82,238 |
|
Other expenses |
|
|
1,572,754 |
|
|
|
1,822,982 |
|
|
|
1,598,986 |
|
Total Operating Expenses |
|
|
18,624,714 |
|
|
|
20,036,389 |
|
|
|
18,164,201 |
|
Net Investment Loss |
|
|
(13,951,287 |
) |
|
|
(13,439,609 |
) |
|
|
(14,708,008 |
) |
Realized Gain/(Loss)
on Investments: |
|
|
|
|
|
|
Non-controlled/non-affiliated
investments |
|
|
8,375,641 |
|
|
|
(1,185,273 |
) |
|
|
(5,835,074 |
) |
Non-controlled/affiliate
investments |
|
|
(6,598,530 |
) |
|
|
(10,762,231 |
) |
|
|
(70,379 |
) |
Controlled investments |
|
|
(6,797,425 |
) |
|
|
— |
|
|
|
— |
|
Net Realized Loss on Investments |
|
|
(5,020,314 |
) |
|
|
(11,947,504 |
) |
|
|
(5,905,453 |
) |
Realized loss on partial repurchase of 6.00% Notes due December 30,
2026 |
|
|
(183,668 |
) |
|
|
— |
|
|
|
— |
|
Change in Unrealized
Appreciation/(Depreciation) of Investments: |
|
|
|
|
|
|
Non-controlled/non-affiliated
investments |
|
|
(30,184,682 |
) |
|
|
10,349,592 |
|
|
|
(109,553,034 |
) |
Non-controlled/affiliate
investments |
|
|
4,429,928 |
|
|
|
20,705,035 |
|
|
|
(1,947,553 |
) |
Controlled investments |
|
|
6,785,776 |
|
|
|
(600,692 |
) |
|
|
(63,005 |
) |
Net Change in Unrealized Appreciation/(Depreciation) of
Investments |
|
|
(18,968,978 |
) |
|
|
30,453,935 |
|
|
|
(111,563,592 |
) |
Net Change in Net Assets Resulting from
Operations |
|
$ |
(38,124,247 |
) |
|
$ |
5,066,822 |
|
|
$ |
(132,177,053 |
) |
Net Change in Net Assets Resulting from Operations per
Common Share: |
|
|
|
|
|
|
Basic |
|
$ |
(1.60 |
) |
|
$ |
0.19 |
|
|
$ |
(4.40 |
) |
Diluted(2) |
|
$ |
(1.60 |
) |
|
$ |
0.19 |
|
|
$ |
(4.40 |
) |
Weighted-Average
Common Shares Outstanding |
|
|
|
|
|
|
Basic |
|
|
23,901,805 |
|
|
|
26,222,667 |
|
|
|
30,023,202 |
|
Diluted(2) |
|
|
23,901,805 |
|
|
|
26,222,667 |
|
|
|
30,023,202 |
|
__________________(1) Includes interest income
earned on cash.(2) For the year ended December 31, 2024, 3,870,969
potentially dilutive common shares were excluded from the
weighted-average common shares outstanding for diluted net decrease
in net assets resulting from operations per common share because
the effect of these shares would have been anti-dilutive. For the
year ended December 31, 2024, there were no potentially dilutive
securities outstanding.
SURO CAPITAL CORP. AND
SUBSIDIARIESFINANCIAL HIGHLIGHTS |
|
|
|
Year Ended December 31, |
|
|
|
2024 |
|
|
|
2023 |
|
|
|
2022 |
|
|
|
2021 |
|
|
|
2020 |
|
Per Basic Share
Data |
|
|
|
|
|
|
|
|
|
|
Net asset value at beginning
of the year |
|
$ |
7.99 |
|
|
$ |
7.39 |
|
|
$ |
11.72 |
|
|
$ |
15.14 |
|
|
$ |
11.38 |
|
Net investment loss(1) |
|
|
(0.58 |
) |
|
|
(0.51 |
) |
|
|
(0.49 |
) |
|
|
(0.38 |
) |
|
|
(0.81 |
) |
Net realized gain/(loss) on investments(1) |
|
|
(0.21 |
) |
|
|
(0.46 |
) |
|
|
(0.20 |
) |
|
|
8.46 |
|
|
|
0.92 |
|
Realized loss on partial repurchase of 6.00% Notes due December 30,
2026(1) |
|
|
(0.01 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Net change in unrealized appreciation/(depreciation) of
investments(1) |
|
|
(0.79 |
) |
|
|
1.16 |
|
|
|
(3.72 |
) |
|
|
(2.39 |
) |
|
|
3.78 |
|
Dividends declared |
|
|
— |
|
|
|
— |
|
|
|
(0.11 |
) |
|
|
(8.00 |
) |
|
|
(0.87 |
) |
Issuance of common stock from stock dividend |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.74 |
|
|
|
— |
|
Issuance of common stock from public offering(1) |
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
|
0.01 |
|
|
|
0.30 |
|
Issuance of common stock from conversion of 4.75% Convertible Notes
due 2023(1) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(1.91 |
) |
|
|
(0.11 |
) |
Repurchase of common stock(1) |
|
|
0.17 |
|
|
|
0.32 |
|
|
|
0.11 |
|
|
|
— |
|
|
|
0.43 |
|
Stock-based compensation(1) |
|
|
0.11 |
|
|
|
0.09 |
|
|
|
0.07 |
|
|
|
0.05 |
|
|
|
0.12 |
|
Net asset value at end of
year |
|
$ |
6.68 |
|
|
$ |
7.99 |
|
|
$ |
7.39 |
|
|
$ |
11.72 |
|
|
$ |
15.14 |
|
Per share market value at end
of year |
|
$ |
5.88 |
|
|
$ |
3.94 |
|
|
$ |
3.80 |
|
|
$ |
12.95 |
|
|
$ |
13.09 |
|
Total return based on market
value(2) |
|
|
49.24 |
% |
|
|
3.68 |
% |
|
|
(69.45 |
)% |
|
|
60.05 |
% |
|
|
99.85 |
% |
Total return based on net
asset value(2) |
|
|
(16.40 |
)% |
|
|
8.12 |
% |
|
|
(36.01 |
)% |
|
|
30.25 |
% |
|
|
33.04 |
% |
Shares outstanding at end of
year |
|
|
23,601,566 |
|
|
|
25,445,805 |
|
|
|
28,429,499 |
|
|
|
31,118,556 |
|
|
|
19,914,023 |
|
Ratios/Supplemental
Data: |
|
|
|
|
|
|
|
|
|
|
Net assets at end of year |
|
$ |
157,572,086 |
|
|
$ |
203,357,646 |
|
|
$ |
210,020,702 |
|
|
$ |
364,846,624 |
|
|
$ |
301,583,073 |
|
Average net assets |
|
$ |
174,438,302 |
|
|
$ |
207,608,591 |
|
|
$ |
310,086,061 |
|
|
$ |
396,209,139 |
|
|
$ |
205,430,809 |
|
Ratio of net operating
expenses to average net assets(3) |
|
|
10.68 |
% |
|
|
9.70 |
% |
|
|
5.87 |
% |
|
|
2.88 |
% |
|
|
7.95 |
% |
Ratio of net investment loss
to average net assets(3) |
|
|
(8.00 |
)% |
|
|
(6.51 |
)% |
|
|
(4.76 |
)% |
|
|
(2.51 |
)% |
|
|
(7.07 |
)% |
Portfolio Turnover Ratio |
|
|
13.73 |
% |
|
|
9.34 |
% |
|
|
4.31 |
% |
|
|
28.34 |
% |
|
|
14.87 |
% |
__________________(1) Based on weighted-average
number of shares outstanding for the relevant period.(2) Total
return based on market value is based upon the change in market
price per share between the opening and ending market values per
share in the period, adjusted for dividends and equity issuances.
Total return based on net asset value is based upon the change in
net asset value per share between the opening and ending net asset
values per share in the period, adjusted for dividends and equity
issuances. (3) For the year ended December 31, 2021, the Company
excluded $100,274 of non-recurring expenses. For the year ended
December 31, 2020, the Company excluded $1,962,431 of non-recurring
expenses. Because the ratios are calculated for the Company’s
common stock taken as a whole, an individual investor’s ratios may
vary from these ratios.
SuRo Capital (NASDAQ:SSSS)
Historical Stock Chart
From Feb 2025 to Mar 2025
SuRo Capital (NASDAQ:SSSS)
Historical Stock Chart
From Mar 2024 to Mar 2025